Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements ; volume:17 ; number:1 ; day:16 ; month:9 ; year:2024 ; pages:1-9 ; date:12.2024
Thyroid research ; 17, Heft 1 (16.9.2024), 1-9, 12.2024

Creator: Uno, Daisuke
Endo, Kazuhira
Yoshikawa, Tomomi
Hirai, Nobuyuki
Kobayashi, Eiji
Nakanishi, Yosuke
Kondo, Satoru
Yoshizaki, Tomokazu

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13044-024-00209-4

URN: urn:nbn:de:101:1-2411010803067.187972714458

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Uno, Daisuke
Endo, Kazuhira
Yoshikawa, Tomomi
Hirai, Nobuyuki
Kobayashi, Eiji
Nakanishi, Yosuke
Kondo, Satoru
Yoshizaki, Tomokazu
SpringerLink (Online service)

Other Objects (12)

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Hochschulschrift

Functional characterization of BRAF mutations in multiple myeloma

Hochschulschrift

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

BRAF mutations in thyroid tumors from an ethnically diverse group

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Hochschulschrift

Functional characterization of BRAF mutations in multiple myeloma

Hochschulschrift

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

BRAF mutations in thyroid tumors from an ethnically diverse group

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Hochschulschrift

Functional characterization of BRAF mutations in multiple myeloma

Hochschulschrift

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

BRAF mutations in thyroid tumors from an ethnically diverse group

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Functional characterization of BRAF mutations in multiple myeloma

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

BRAF mutations in thyroid tumors from an ethnically diverse group

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Functional characterization of BRAF mutations in multiple myeloma

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

BRAF mutations in thyroid tumors from an ethnically diverse group

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas

Functional characterization of BRAF mutations in multiple myeloma

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

BRAF mutations in thyroid tumors from an ethnically diverse group

Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer

TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Related objects

Reset password